The effect of hepatic disease on the dis
β
Henry J. Pieniaszek Jr; Anna F. Davidson; Carol M. McEntegart; Check Y. Quon; Ri
π
Article
π
1994
π
John Wiley and Sons
π
English
β 522 KB
## Abstract The pharmacokinetics of moricizine and two of its metabolites, moricizine sulfoxide and phenothiazineβ2βcarbamic acid ethyl ester sulfoxide, were studied in healthy control subjects and in patients with chronic liver disease (cirrhosis). Moricizine disposition was significantly altered